Company overview
Basic information
Company name
UKVAISTA, UAB
Company code
183217118
VAT code
LT832171113
Registered address
Ukmergė, Vasario 16-osios g. 35, LT-20129
Registration date
2001-12-11
Company age: 24 y. 9 mo.
Contact information
Edit data
Phone
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
Uždaroji akcinė bendrovė "UKVAISTA"
Company code: 183217118
Address: Ukmergė, Vasario 16-osios g. 35, LT-20129
VAT code: LT832171113
Download a detailed company report
Make confident decisions with all the information about UKVAISTA, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
UKVAISTA, UAB is an operational private limited liability company registered in 2001. It operates as a private company in the sector of national private non-financial companies, under private ownership where Lithuanian natural and legal persons hold more than 50% of the authorised capital and there is no foreign investor capital. The company is governed by a CEO only and is classified as a micro company. Its registered address is Ukmerge, Vasario 16-osios g. 35, LT-20129, in Ukmerges district municipality, Vilnius County. The company’s activity is retail sale of pharmaceutical products (EVRK G.47.73.00). In financial year 2025, UKVAISTA generated revenue of EUR 894.9K, up 40.4% year on year and 42.4% over two years, with net profit of EUR 78.6K and a profit margin of 8.8%. Equity stood at EUR 474.3K, total assets at EUR 519.2K, and liabilities at EUR 44.9K. The company reported strong profitability ratios, including ROE of 16.6% and ROA of 15.1%. Average employment reached 10 so far in 2026, compared with 9 in 2025, and the average monthly wage was EUR 945.02 so far in 2026.